Search results for "OBESITY"

showing 10 items of 1833 documents

There is a relationship between obesity and COVID‐19 but more information is needed

2020

Abstract We read with particular interest your comments in Obesity regarding the Coronavirus‐19 (COVID‐19) epidemic (1) and a related manuscript by Simonnet et al. (2). Resolution of the specific relationship between obesity and COVID‐19, two existing public health epidemics, is critically needed to potentially prevent health systems worldwide from being overburdened. Few studies describing COVID‐19 with rates of obesity exist, and most are based on heterogeneous populations (Table 1) (2‐7). In cohort studies with COVID‐19 disease, obesity rates are generally reported as no higher than population‐based estimates; in contrast, subgroups of critically ill patients (e.g, intensive care unit (I…

Critical CareSARS-CoV-2Pneumonia ViralCOVID-19Social SupportComorbiditySeverity of Illness Indexobesity COVID-19 incidence prevalenceUnited StatesBetacoronavirusSocial IsolationRisk FactorsHumansObesitySettore MED/49 - Scienze Tecniche Dietetiche ApplicateLetters to the EditorCoronavirus InfectionsLetter to the EditorPandemicsObesity (Silver Spring, Md.)
researchProduct

Weight control behaviors among overweight, normal weight and underweight adolescents in Palestine: findings from the national study of Palestinian sc…

2009

Objective: The objective of the study is to examine the relationship between weight-control behaviors and selfreported sociodemographic characteristics, weight status, and perception of body weight in a large, representative sample of adolescents in the West Bank and Gaza Strip territories of Palestine. Method: Self-report measures of sociodemographic characteristics, body weight perception, height and weight, and weight-control behaviors were completed by 8,885 male and female students aged 12–18 years from 405 randomly selected schools as part of the 2003/2004 Palestinian Health Behavior in School-aged Children Study (HBSC). Results: In both genders, dieting to lose weight was common amon…

Cross-Cultural ComparisonMaleAdolescentDiet ReducingCross-sectional studyHealth BehaviorOverweightDevelopmental psychologyMiddle EastSex FactorsThinnessmedicineBody ImageHumansChildbusiness.industryBody WeightAge FactorsFeeding BehaviorOverweightmedicine.diseaseCross-cultural studiesObesityHealth SurveysArabsPsychiatry and Mental healthCross-Sectional StudiesSocioeconomic FactorsPillFemalemedicine.symptomUnderweightbusinessBody mass indexDietingDemographyThe International journal of eating disorders
researchProduct

Surgery for obesity.

2005

PURPOSE OF REVIEW Bariatric surgery today is the only effective therapy for morbid obesity. Commonly performed procedures include adjustable gastric banding and vertical banded gastroplasty, variations of the Roux-en-Y gastric bypass, biliopancreatic diversion or duodenal switch, and mixed procedures. This review discusses key issues in the surgical management of morbid obesity. RECENT FINDINGS The two most common bariatric procedures performed worldwide are laparoscopic adjustable gastric banding and laparoscopic Roux-en-Y gastric bypass. Controversy exists regarding the best surgical procedure. Weight loss decreases according to the procedures performed in following decreasing order: bili…

Cultural Studiesmedicine.medical_specialtyGastroplastyCost effectivenessbusiness.industrymedicine.medical_treatmentCost-Benefit AnalysisGastric BypassBariatric SurgeryPerioperativemedicine.diseaseObesityDuodenal switchEducationSurgeryMorbid obesityQuality of lifeWeight lossmedicineHumansmedicine.symptombusinessBiliopancreatic DiversionCurrent opinion in gastroenterology
researchProduct

Impact of body weight on virological and immunological responses to efavirenz-containing regimens in HIV-infected, treatment-naive adults

2015

Objective: The prevalence of overweight and obesity is increasing among HIV-infected patients. Whether standard antiretroviral drug dosage is adequate in heavy individuals remains unresolved. We assessed the virological and immunological responses to initial efavirenz (EFV)-containing regimens in heavy compared to normal-weight HIV-infected patients. Design: Observational European cohort collaboration study. Methods: Eligible patients were antiretroviral-naive with documented weight prior to EFV start and follow-up viral loads after treatment initiation. Cox regression analyses evaluated the association between weight and time to first undetectable viral load ( 50 copies/ml) after initial s…

CyclopropanesMaleEfavirenz; HIV; Immunological response; Virological response; Weight; Adult; Antiretroviral Therapy Highly Active; Benzoxazines; CD4 Lymphocyte Count; Cohort Studies; Female; HIV Infections; Humans; Male; Middle Aged; Obesity; Regression Analysis; Reverse Transcriptase Inhibitors; Treatment Outcome; Viral Load; Body WeightHIV InfectionsOverweight10234 Clinic for Infectious DiseasesCohort Studieschemistry.chemical_compoundAntiretroviral Therapy Highly ActiveImmunology and AllergyHIV InfectionImmunological responsevirus diseasesVirological responseMiddle AgedViral LoadReverse Transcriptase InhibitorTreatment OutcomeInfectious DiseasesAlkynesCohort2723 Immunology and AllergyRegression AnalysisReverse Transcriptase InhibitorsFemalemedicine.symptomViral loadCohort studyHumanBenzoxazineAdultmedicine.medical_specialtyEfavirenzImmunologyAntiretroviral Therapy610 Medicine & healthRegression AnalysiPharmacokineticsInternal medicinemedicineHumansHighly ActiveObesity2403 Immunologybusiness.industryProportional hazards modelBody WeightHIV2725 Infectious DiseasesEfavirenz; HIV; Immunological response; Virological response; Weight; Adult; Antiretroviral Therapy Highly Active; Benzoxazines; CD4 Lymphocyte Count; Cohort Studies; Female; HIV Infections; Humans; Male; Middle Aged; Obesity; Regression Analysis; Reverse Transcriptase Inhibitors; Treatment Outcome; Viral Load; Body Weight; Immunology and Allergy; Immunology; Infectious Diseasesmedicine.diseaseWeightObesityBenzoxazinesCD4 Lymphocyte Countlnfectious Diseases and Global Health Radboud Institute for Health Sciences [Radboudumc 4]chemistryImmunologyCohort StudieEfavirenzbusiness
researchProduct

Change in weight and central obesity by positive airway pressure treatment in obstructive sleep apnea patients: longitudinal data from the ESADA coho…

2018

The effect of positive airway pressure treatment on weight and markers of central obesity in patients with obstructive sleep apnea remains unclear. We studied the change in body weight and anthropometric measures following positive airway pressure treatment in a large clinical cohort. Patients with obstructive sleep apnea with positive airway pressure treatment from the European Sleep Apnea Database registry (n = 1, 415, 77% male, age 54 ± 11 [mean ± SD] years, body mass index 31.7 ± 6.4 kg/m2, apnea–hypopnea index 37 ± 24 n per hr, Epworth Sleepiness Scale 10.2 ± 5.0) were selected. Changes in body mass index and neck/waist/hip circumferences at baseline and at follow-up visit were analyse…

Data AnalysisMaleTime FactorsExcessive daytime sleepinessWeight Gainexcessive daytime sleepineBody Mass IndexCohort StudiesBehavioral Neuroscience0302 clinical medicinePositive airway pressureMedicineLongitudinal StudiesProspective Studiesobstructive sleep apneaSleep Apnea ObstructiveContinuous Positive Airway PressureEpworth Sleepiness ScaleSleep apneaGeneral MedicineMiddle Agedweight ; central obesity ; positive airway pressure ; obstructive sleep apnea ; ESADA cohortEuropeObesity AbdominalCardiologyFemaleWaist Circumferencemedicine.symptomAdultmedicine.medical_specialtyCognitive NeuroscienceSettore MED/10 - Malattie Dell'Apparato Respiratorio03 medical and health sciencesInternal medicineHumanspositive airway pressureAgedcentral obesitybusiness.industryBody Weightbody weight central obesity excessive daytime sleepiness obstructive sleep apnea positive airway pressureta3121medicine.diseaseObesityrespiratory tract diseasesObstructive sleep apnea030228 respiratory systemHuman medicinebusinessBody mass indexWeight gain030217 neurology & neurosurgery
researchProduct

Maternal body mass index, gestational weight gain, and the risk of overweight and obesity across childhood: An individual participant data meta-analy…

2019

Background Maternal obesity and excessive gestational weight gain may have persistent effects on offspring fat development. However, it remains unclear whether these effects differ by severity of obesity, and whether these effects are restricted to the extremes of maternal body mass index (BMI) and gestational weight gain. We aimed to assess the separate and combined associations of maternal BMI and gestational weight gain with the risk of overweight/obesity throughout childhood, and their population impact. Methods and findings We conducted an individual participant data meta-analysis of data from 162,129 mothers and their children from 37 pregnancy and birth cohort studies from Europe, No…

Data AnalysisembarazoMaternal HealthBlood PressureCHILDRENWeight GainCardiovascularVascular MedicineBody Mass Index0302 clinical medicineEndocrinologyPregnancyMedicineMass indexestudios de cohortesCancer030219 obstetrics & reproductive medicineStatisticsWOMENta3141General Medicine030220 oncology & carcinogenesisMeta-analysisPhysical SciencesMedicineGestationHEALTHINTERVENTIONChildhood ObesityEndocrine Disorders03 medical and health sciencesHypertensive Disorders in PregnancyClinical ResearchDiabetes MellitusHumansGestational DiabetesStatistical MethodsPregnancyIndividual participant dataPreventionAustraliaBiology and Life SciencesOdds ratiomedicine.diseaseObesityGeneric health relevanceBody mass indexMathematicsDemographyPediatric ObesityNutrition and DiseasePhysiologyhumanosReproductive health and childbirth030204 cardiovascular system & hematologyOverweightMedical and Health SciencesOral and gastrointestinalCohort StudiesMathematical and Statistical TechniquesRisk FactorsVoeding en ZiekteOFFSPRING OBESITYMedicine and Health Sciences030212 general & internal medicineChildhood obesity2. Zero hungerPediatricsobrepesoMedicine (all)RObstetrics and GynecologyMetaanalysis3142 Public health care science environmental and occupational healthGestational Weight Gainobesidad pediátricaEuropeStrokePREGNANCYPhysiological Parametersgestational weight gain pregnancy obesityHypertensionFemalemedicine.symptomResearch ArticleBIRTH[SDV.MHEP.GEO]Life Sciences [q-bio]/Human health and pathology/Gynecology and obstetricsResearch and Analysis MethodsChildhood obesityGeneral & Internal Medicinefactores de riesgoLife ScienceObesityMetabolic and endocrineNutritionbusiness.industryíndice de masa corporalBody WeightOverweight3121 General medicine internal medicine and other clinical medicineMetabolic DisordersNorth AmericaWomen's HealthbusinessMaternal bodyGestiational diabetesWeight gainPLOS Medicine
researchProduct

Modulation of Irisin and Physical Activity on Executive Functions in Obesity and Morbid obesity

2016

Whether the executive profile is different between obesity (OB) and morbid obesity (MO) remains unclear. Recent evidence suggests that physical activity (PA) can act as a cognitive enhancer. Irisin is a recently discovered hormone associated with some of the positive effects of PA. The objective of the study was to investigate the executive profile in OB and MO, and to explore the role of PA and irisin. 114 participants were included (21 OB, 44 MO and 49 healthy controls-HC) in the study and assessed with the Wisconsin Card Sorting Test, Stroop Color and Word Test, and Iowa Gambling Task. All participants were female, aged between 18 and 60 years. Results showed a similar dysfunctional prof…

DecisionObesitat mòrbida -- TractamentMorbid obesity0302 clinical medicineWisconsin Card Sorting TestObesity -- TreatmentMorbid obesity -- TreatmentMultidisciplinaryNeuropsychologyExercici -- Aspectes fisiològicsCognitionMiddle AgedExecutive functionsObesity MorbidObesitat -- TractamentCognitive controlObesitatFemaleClinical psychologyAdultIrisinmedicine.medical_specialtyAdolescentDecision MakingObesitat mòrbidaDysfunctional profile030209 endocrinology & metabolismDysfunctional familyPredictive markersArticle03 medical and health sciencesInternal medicinemedicineHumansObesityExercisePhysical activitybusiness.industryPhysical fitnessmedicine.diseaseObesityIowa gambling taskHormonesFibronectinsEndocrinologybusinessDecision making030217 neurology & neurosurgeryStroop effectCondició físicaScientific Reports
researchProduct

Defensive strategies in a big obese group [MECCANISMI DI DIFESA IN UN GRUPPO DI PERSONE CON OBESITA']

2013

Aim. The aim of this study was to explore thè defense mechanisms of people with moderate and severe obesity. In fact, thè defensive structure is an effective predictor for thè best management of thè disease. Methods. 204 people (164 F-40 M) bave been recruited: 40 with BMI between 30 and 34.9, with moderate obesity, 36 with BMI between 35 and 39.9, with severe obesity, and 128 with BMI>40, with serious obesity, ali of them pertaining to thè clinic for obesity treatment at University Hospital of Palermo. Ali subjects were administered thè Defense Mechanisms Inventory (DMI), a type of reactive that explores defense mechanisms. The psychiatric comorbidity was excluded by thè DSM (SCIDI and II)…

Defence mechanismSettore M-PSI/08 - Psicologia ClinicaObesityTherapeuticsSettore MED/25 - PsichiatriaSettore MED/39 - Neuropsichiatria Infantile
researchProduct

Obesity and nonalcoholic fatty liver disease in type 1 diabetes mellitus patients

2022

nessuno

Diabetes Mellitus Type 1EndocrinologyNon-alcoholic Fatty Liver DiseaseEndocrinology Diabetes and MetabolismInternal MedicineHumansObesityCardiometabolic risk Diabetes mellitus type 1 Metabolic syndrome Nonalcoholic Nonalcoholic fatty liver disease Obesity SteatohepatitisJournal of Diabetes and its Complications
researchProduct

Efficacy of GLP-1 RA Approved for Weight Management in Patients With or Without Diabetes: A Narrative Review

2022

The approval of once daily liraglutide, 3.0 mg, and once weekly semaglutide, 2.4 mg, for chronic weight management provides a novel effective strategy against obesity. The reliable models that might predict weight reducing potential at the individual level have not been identified yet. However, the coexistence of diabetes has been consistently related with less effective response than in people without this comorbidity. We aimed to review the efficacy of GLP-1 RAs approved for weight management in individuals with and without diabetes and discuss some potential mechanisms for consistently observed differences in efficacy between these two populations. The mean weight loss difference between…

Diabetes Mellitus Type 2Glucagon-Like Peptide 1Weight LossGlucagon-Like PeptidesDiabetes GLP-1 RAs Liraglutide Obesity SemaglutideHumansHypoglycemic AgentsPharmacology (medical)ObesityGeneral MedicineLiraglutideWeight GainGlucagon-Like Peptide-1 Receptor
researchProduct